Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Federal Reserve May Face Limited Justification for Interest Rate Cuts as Jobs Report Highlights Persistent Cost of Living Pressures Spains Youth Housing Crisis Rent Absorbs 987 of Wages Emancipation Plummets to Record Low Walmart Warns US Consumers May Reduce Spending Amid Rising Petrol Prices Singapores Young Professionals Earn High Incomes but Struggle with Financial Insecurity Amid Rising Living Standards Consolidation Dynamics Reshape US Nitrogen Fertilizer Sector C3ai Q1 2026 Earnings WiderThanExpected Loss and Tepid Market Reception Xeris Biopharma XERS Q1 2026 Earnings Surprise Profitability as EPS Beats Estimates BRBS Q1 2026 Earnings Return to Profitability with Positive EPS of 002 Victorias Secret Co VSCO Q1 2026 Earnings Earnings Beat Estimates as Company Reports Strong Profitability Phibro Animal Health PAHC Q1 2026 Earnings EPS Surges Past Estimates Stock Dips Despite Beat Hercules Capital 625 Notes Due 2033 HCXY Holds Steady Near Support as FixedIncome Market Watches Rate Signals High Tide Inc HITI Slips 205 as Traders Eye Key Support at 227 MESHW Warrants Hold Steady at 030 Quiet Session for Meshflow Acquisition Corp Capital Bancorp Inc CBNK Holds Steady Near Key Resistance After Marginal Decline Meta Plans 6065 Billion AI Investment Signaling Accelerated Tech Spending on Data Centers Flex COO Tan Kwang Hooi Sells 238 Million in Company Stock China Accelerates Robot Training for Workforce as Musk Flags Competition in Humanoid Robotics Consumer Credit Growth Surges in December Signaling Strong Consumer Demand Ganga Expressway Projected to Slash Freight Time and Generate 30000 Crore in Annual Logistics Savings APEC Summit Reveals Persistent USChina Trade Rifts Despite Recent Talks US Government Stake in Quantum Companies Sparks Speculation on Next Targets SpaceXs Future SP Sector Classification Rockets Satellites or Tech Amazon Raised Over 1 Billion Through Allegedly Illegal Pricing Algorithm FTC Claims Gain Therapeutics Maintains Outperform Rating at Oppenheimer Amid Pipeline Progress